MedTrace Logo

Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia

NCT02141412 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2018-06-27

No results posted yet for this study

Summary

In a prospective randomized clinical trial involving adult patients undergoing elective surgery under general anesthesia, the investigators will enroll 216 patients, and evaluate 3 doses of prophylactic dexmedetomidine as a means to reduce postoperative shivering and quality of emergence from anesthesia versus placebo.

Conditions

  • Anesthesia Recovery
  • Anesthesia Emergence
  • Shivering
  • Postoperative Recovery

Interventions

DRUG

dexmedetomidine 0.25 µg/kg IV

DRUG

dexmedetomidine 0.5 µg/kg IV

DRUG

dexmedetomidine 1 µg/kg IV

DRUG

Placebo Comparator

Patients in Group IV will receive same volume of normal saline at closure of sevoflurane

Sponsors & Collaborators

  • American University of Beirut Medical Center

    lead OTHER

Principal Investigators

  • Marie Aouad, MD · American Univesity of Beirut Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02141412 on ClinicalTrials.gov